All news

Medtronic upgraded to buy at Wall Street Zen

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Wall Street Zen upgraded Medtronic (NYSE:MDT) to a buy rating, matching a Moderate Buy consensus among analysts. The average price target sits at

Read original source

MDT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.